Source study found

Story checked

Hemoglobin component heme shown to inhibit enzyme that helps dissolve blood clots (opens in a new tab)

medicalxpress.com · 2026-10-26

Short answerEvidenceSource

Short answer

Supported

Supported.

The story matches what the study reports.

4 supported

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Hemoglobin component heme shown to inhibit enzyme that helps dissolve blood clots

medicalxpress.com · 2026-10-26

The story’s checkable claims.

Read the original story

NewsLink checks it

Supported

Every claim holds up. All four claims match what the study reports.

4 supported

Open claim evidence

The source study

Attenuation of fibrinolysis through heme binding to the serine protease plasmin

International Journal of Biological Macromolecules · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

4 claims in this story

Showing all 4 claimsChoose a verdict to focus the list.

Claim 1 of 4SupportedA team of researchers at the University of Koblenz, led by Prof. Dr. Marie-T. Hopp, has demonstrated that heme—a component of hemoglobin—can influence blood-clot breakdown.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the scientific core: heme binding produces inhibition of plasmin-mediated fibrinolysis, i.e., it can influence blood-clot/fibrin breakdown. The supplied paper profile does not independently verify the University of Koblenz affiliation or named leadership, but the mechanistic claim is supported.

Study evidence

Heme binding causes a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels described as consistent with pathological hemolysis.Pronounced, concentration-dependent inhibition (magnitude and quantitative parameters not reported in the abstract)

“Importantly, heme binding resulted in a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels consistent with pathological hemolysis.”

Claim 2 of 4SupportedThe researchers say plasmin binds heme with high affinity, and they identified six potential heme-binding sites on plasmin after biochemical, biophysical, peptide, and computer-simulation analyses.View evidenceHide evidence

As statedsix potential heme-binding sites

Why this verdict

The profile supports high-affinity heme binding to plasmin, with SPR reporting nanomolar affinity. It also supports identification of six discrete heme-binding motifs by peptide mapping, with docking and molecular dynamics used to evaluate candidate motifs and propose stable coordination at three surface-exposed sites. The story’s wording is broadly consistent, though the abstract-level profile distinguishes six peptide-mapped motifs from three computationally supported surface coordination sites.

Study evidence

Plasmin binds heme with nanomolar affinity (measured by SPR) and exhibits an overstoichiometric heme-binding capacity (measured by UV/visible spectroscopy).nanomolar

“Surface plasmon resonance and UV/visible spectroscopy revealed nanomolar binding affinity and an overstoichiometric heme-binding capacity of plasmin, respectively.”

Study evidence

Systematic mapping with plasmin-derived peptides uncovered six discrete heme-binding motifs.

“Systematic mapping with plasmin-derived peptides uncovered six discrete heme-binding motifs”

Claim 3 of 4SupportedBound heme significantly inhibits plasmin's ability to break down blood clots, with the extent of inhibition depending on heme concentration, and the effect was observed at concentrations that can occur in pathological hemolysis.View evidenceHide evidence

Why this verdict

The profile directly reports that heme binding resulted in pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels described as consistent with pathological hemolysis. This supports the causal in-vitro mechanism as stated. The abstract profile does not provide quantitative effect sizes, exact heme concentrations, or assay details.

Study evidence

“Importantly, heme binding resulted in a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels consistent with pathological hemolysis.”

Claim 4 of 4SupportedThe article says the findings may help explain why people with certain hemolytic disorders face an increased risk of thrombosis, but further research is needed to determine whether the heme-plasmin interaction actually plays a role in patients.View evidenceHide evidence

Why this verdict

The profile supports a cautious interpretation that excess labile heme may impair fibrinolysis and relate to a prothrombotic phenotype in hemolytic disorders, while also noting no in-vivo confirmation or direct patient demonstration in the abstract. The story’s caveat that patient relevance remains to be determined matches this limitation.

Study evidence

“Importantly, heme binding resulted in a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels consistent with pathological hemolysis.”

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

UV/visible spectroscopy indicated overstoichiometric heme-binding capacity of plasmin.
The story mentions high-affinity binding but does not reflect the separate overstoichiometric binding-capacity finding.
From in vitro binding assays (SPR and UV/Vis)
Molecular docking and molecular dynamics simulations suggested stable heme coordination at three surface-exposed sites near functional regions of plasmin.
The story mentions computer-simulation analyses but, as presented, does not capture the profile’s distinction that computational work refined the mapping to three stable surface-exposed coordination sites rather than simply validating all six motifs as equivalent sites.
From computational docking and molecular dynamics

4 things the story did carry across

Plasmin is identified as a high-affinity heme-binding protein, with nanomolar affinity measured by SPR and binding capacity characterized by UV/visible spectroscopy.
Systematic peptide mapping identified six discrete heme-binding motifs on plasmin.
Heme binding produces pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels consistent with pathological hemolysis.
The functional and binding findings are abstract-reported in-vitro/basic-research evidence, with no direct in-vivo or patient demonstration of prothrombotic consequences in the supplied profile.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroDemonstrate functional consequences of heme binding on plasmin activity—attenuation of plasmin-mediated fibrinolysis at pathophysiologically relevant heme levels.Expand

In plain English

Using in vitro plasmin functional/fibrinolysis assays with heme titration, the study reports that heme binding produces a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis; the inhibitory effect is stated to occur at heme concentrations described as consistent with pathological hemolysis.

Key findings

Heme binding causes a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels described as consistent with pathological hemolysis.Pronounced, concentration-dependent inhibition (magnitude and quantitative parameters not reported in the abstract)

“Importantly, heme binding resulted in a pronounced, concentration-dependent inhibition of plasmin-mediated fibrinolysis at heme levels consistent with pathological hemolysis.”

What this piece can’t prove

Unclear whether functional inhibition was demonstrated in physiologically complex systems (e.g., plasma or whole blood) or only in simplified/purified in vitro systems.

2 further details could not be confirmed from the summary.

2in vitroIdentify plasmin as a high-affinity heme-binding protein and quantify/characterize the binding interaction.in vitro binding assays (SPR and UV/Vis)Expand

In plain English

Surface plasmon resonance (SPR) and UV/visible spectroscopy on purified components indicate that plasmin is a high-affinity heme-binding protein: SPR reports nanomolar binding affinity and UV/Vis indicates an overstoichiometric heme-binding capacity.

Key findings

Plasmin binds heme with nanomolar affinity (measured by SPR) and exhibits an overstoichiometric heme-binding capacity (measured by UV/visible spectroscopy).nanomolar

“Surface plasmon resonance and UV/visible spectroscopy revealed nanomolar binding affinity and an overstoichiometric heme-binding capacity of plasmin, respectively.”

What this piece can’t prove

Results derive from in vitro binding assays with purified components and may not capture in vivo complexity or regulatory factors.

1 further detail could not be confirmed from the summary.

3in vitroMap discrete heme-binding motifs/sites on plasmin and propose structural coordination models for heme binding.peptide mappingExpand

In plain English

The study performed systematic mapping with plasmin-derived peptides and identified six discrete heme-binding motifs; these peptide-mapped sites were used to propose structural coordination models supported by molecular docking and molecular dynamics simulations.

Key findings

Systematic mapping with plasmin-derived peptides uncovered six discrete heme-binding motifs.

“Systematic mapping with plasmin-derived peptides uncovered six discrete heme-binding motifs”

What this piece can’t prove

Unclear whether peptide-identified motifs were experimentally validated in the intact plasmin protein beyond computational modelling.

3 further details could not be confirmed from the summary.

4in silicoMap discrete heme-binding motifs/sites on plasmin and propose structural coordination models for heme binding.computational docking and molecular dynamicsExpand

In plain English

Computational evaluation (molecular docking and molecular dynamics simulations) of plasmin-derived heme-binding motifs refined peptide-mapping results and proposed structural coordination at three surface-exposed sites near functional regions of plasmin.

Key findings

Docking and MD simulations suggested stable heme coordination at three surface-exposed sites on plasmin, located proximal to functional regions.

“which were further evaluated by molecular docking and molecular dynamics simulations, suggesting stable coordination at three surface-exposed sites”

What this piece can’t prove

Summary is based solely on the abstract; methodological specifics and quantitative outputs (binding energies, simulation lengths, stability metrics) are not available here.

1 further detail could not be confirmed from the summary.

Finally, the search trail

Method layer